Page last updated: 2024-08-23

calcium dobesilate and Kidney Diseases

calcium dobesilate has been researched along with Kidney Diseases in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's5 (71.43)2.80

Authors

AuthorsStudies
Ashraful-Haque, SZ; Che, JJ; Chen, KY; Guo, SH; Li, GP; Liu, T; Rha, SW; Tao, HY; Wang, JR; Xue, ZK; Zhang, H; Zhang, YR1
Damankhorshid, M; Fatemi, I; Giménez-Llort, L; Hakimizadeh, E; Kaeidi, A; Kujawska, M; Moradbeygi, K; Nikbakhtzadeh, M; Sciorati, C; Taghipour, Z; Zamanian, MY1
Li, S; Liu, C; Sun, D; Wang, N; Wang, Y; Zuo, B1
Amirteimoury, M; Bazmandegan, G; Fatemi, I; Fathinejad, A; Kaeidi, A; Khademalhosseini, M1
Cao, J; Chen, K; Shen, H1
Nasri, H1
Changizi Ashtiyani, S; Jafarey, M; Najafi, H1

Trials

2 trial(s) available for calcium dobesilate and Kidney Diseases

ArticleYear
Calcium dobesilate protects against d-galactose-induced hepatic and renal dysfunction, oxidative stress, and pathological damage.
    Fundamental & clinical pharmacology, 2022, Volume: 36, Issue:4

    Topics: Animals; Antioxidants; Calcium Dobesilate; Galactose; Kidney; Kidney Diseases; Liver; Male; Mice; Oxidative Stress; Superoxide Dismutase

2022
Calcium dobesilate for prevention of gentamicin-induced nephrotoxicity in rats.
    Iranian journal of kidney diseases, 2014, Volume: 8, Issue:1

    Topics: Animals; Blood Urea Nitrogen; Calcium Dobesilate; Creatinine; Disease Models, Animal; Ferric Compounds; Gentamicins; Hemostatics; Kidney; Kidney Diseases; Male; Malondialdehyde; Osmolar Concentration; Oxidative Stress; Potassium; Rats; Rats, Sprague-Dawley; Sodium; Urea

2014

Other Studies

5 other study(ies) available for calcium dobesilate and Kidney Diseases

ArticleYear
Effect of Calcium Dobesilate in Preventing Contrast-Induced Nephropathy in Patients with Diabetes and Chronic Kidney Disease.
    Clinics (Sao Paulo, Brazil), 2021, Volume: 76

    Topics: Biomarkers; Calcium Dobesilate; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Glomerular Filtration Rate; Humans; Kidney Diseases; Percutaneous Coronary Intervention; Renal Insufficiency, Chronic

2021
Calcium dobesilate mediates renal interstitial fibrosis and delay renal peritubular capillary loss through Sirt1/p53 signaling pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 132

    Topics: Animals; Apoptosis; Calcium Dobesilate; Capillaries; Disease Models, Animal; Disease Progression; Fibrosis; Hemostatics; Human Umbilical Vein Endothelial Cells; Humans; Kidney Diseases; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Sirtuin 1; Tumor Suppressor Protein p53

2020
Calcium dobesilate prevents cisplatin-induced nephrotoxicity by modulating oxidative and histopathological changes in mice.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:3

    Topics: Animals; Antineoplastic Agents; Blood Urea Nitrogen; Calcium Dobesilate; Cisplatin; Creatinine; Glutathione Peroxidase; Kidney; Kidney Diseases; Male; Malondialdehyde; Mice; Oxidative Stress; Protective Agents; Superoxide Dismutase

2021
A new method for anti-negative interference of calcium dobesilate in serum creatinine enzymatic analysis.
    Journal of clinical laboratory analysis, 2021, Volume: 35, Issue:9

    Topics: Artifacts; Biomarkers; Blood Chemical Analysis; Calcium Dobesilate; Clinical Enzyme Tests; Creatinine; Hemostatics; Humans; Kidney Diseases; Kidney Function Tests; Sarcosine Oxidase

2021
Antioxidants for prevention of gentamicin-induced nephrotoxicity.
    Iranian journal of kidney diseases, 2014, Volume: 8, Issue:1

    Topics: Animals; Calcium Dobesilate; Hemostatics; Kidney; Kidney Diseases; Male

2014